Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Clinical trial NCT06136624 · RECRUITING

Trial details

NCT number: NCT06136624
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2023-12-31
Primary completion: 2028-08-02
Enrollment: 1310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.